Research Analysts Issue Forecasts for IPSC Q3 Earnings
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Analysts at William Blair issued their Q3 2026 EPS estimates for shares of Century Therapeutics in a research note issued to investors on Thursday, March 20th. William Blair analyst S. Corwin anticipates that the company will earn ($0.47) per share for the quarter. The consensus estimate for […]
